☆ 4.6 Article

Value of 18F-FDG PET/CT for Early Prediction of Pathologic Response (by Residual Cancer Burden Criteria) of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy

CLINICAL NUCLEAR MEDICINE (2014)

Journal

CLINICAL NUCLEAR MEDICINE

Volume 39, Issue 10, Pages 882-886

Publisher

Ovid Technologies (Wolters Kluwer Health)

DOI: 10.1097/rlu.0000000000000531

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Value of 18F-FDG PET/CT for Early Prediction of Pathologic Response (by Residual Cancer Burden Criteria) of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy

Journal

CLINICAL NUCLEAR MEDICINE

Publisher

Ovid Technologies (Wolters Kluwer Health)

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Value of 18F-FDG PET/CT for Early Prediction of Pathologic Response (by Residual Cancer Burden Criteria) of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy

Journal

CLINICAL NUCLEAR MEDICINE

Publisher

Ovid Technologies (Wolters Kluwer Health)

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper